The Neuroimmunology Laboratory at Ondokuz Mayıs University (OMU) Faculty of Medicine stands out with its groundbreaking work in the diagnosis of neurological diseases. Renowned as the most comprehensive laboratory in Türkiye, the center provides critical services for diseases such as multiple sclerosis (MS) and myasthenia gravis. Prof. Dr. Murat Terzi, Head of OMU Faculty of Medicine’s Neurology Department and President of the Turkish Neurology Association, stated, “Our laboratory is a world-class facility capable of archiving blood and cerebrospinal fluid samples and collaborating with numerous researchers.”
Established seven years ago, the Neuroimmunology Laboratory at OMU has gained recognition for its advanced diagnostic and immunological research in neurology. Serving patients from across Türkiye and neighboring countries, the laboratory conducts studies at global academic standards. Highlighting the laboratory's future goals, Prof. Dr. Terzi noted its plans to expand collaborations with countries like Azerbaijan and Macedonia to support health tourism. “In our seventh year, our goal for 2025 is to increase research and production while meeting all diagnostic needs for patients academically,” he added.
Prof. Dr. Terzi invited all researchers in the field to utilize the laboratory for their studies, stating, “OMU’s Neuroimmunology Laboratory provides diagnostic services for neurological and immune-related diseases. We analyze blood and cerebrospinal fluid samples to diagnose conditions such as MS, vision loss, and limb weakness. Results are processed within a few days and shared with relevant clinics. We receive samples from nearly every city in Türkiye and neighboring regions.”
Professor Dr. Terzi highlighted the lab's extensive archives and research contributions, “Our laboratory is the most comprehensive in its field among state universities and institutions. Over the past seven years, we have consistently increased the number of samples processed daily. Beyond diagnostics, we archive blood and cerebrospinal fluid samples for academic purposes. Our work meets international standards, and we collaborate extensively with researchers using our vast archives, which include thousands of cerebrospinal fluid samples.”
Prof. Dr. Terzi also emphasized the recent advancements in myasthenia gravis diagnostics, stating, “In the last two years, we developed and implemented acetylcholine receptor antibody testing for myasthenia gravis, offering this service to the entire country. Economically, we operate without profit, focusing solely on academic and scientific contributions while maintaining routine services and advancing research and development efforts.”
DİNLE